Over 30% of adults in the United States report knowing someone who has died from a fatal drug overdose, according to the results from a survey published in the journal JAMA Health Forum.1 The authors of the study said that the experience of losing someone to an overdose was associated with a higher likelihood of endorsing addiction as a key policy issue.
According to data from the CDC, there were an estimated 111,029 drug overdose deaths in 2022, with nearly 70% of them due to synthetic opioids such as fentanyl. Although this number dropped slightly in 2023—down about 3% to 107,543—it still represents a significant increase from just over a decade ago and has impacted people all over the country.2
Key Takeaways
- Over 30% of U.S. adults report knowing someone who has died from a drug overdose, highlighting the widespread impact of the overdose crisis.
- Experiencing the loss of a family member or close friend to a drug overdose is linked to an increased likelihood of viewing addiction as a crucial policy issue, emphasizing the need for policy changes to address the crisis.
- The burden of personal overdose loss is greater among individuals with lower incomes, illustrating the intersection of economic precarity and the impact of the overdose crisis.
“The drug overdose crisis is a national tragedy,” Alene Kennedy-Hendricks, PhD, an assistant professor in the Department of Health Policy and Management at the Bloomberg School and a lead author on the study, said in a release.3 “Although large numbers of US adults are bereaved due to overdose, they may not be as visible as other groups who have lost loved ones to less stigmatized health issues. Movements to build support for policy change to overcome the devastating toll of the overdose crisis should consider the role of this community.”
READ MORE: Tianeptine Misuse Raises Concerns Across US, but is Stigmatizing the Drug Helpful?
Investigators from the Johns Hopkins Bloomberg School of Public Health conducted a cross-sectional study to “quantify the scope of the drug overdose crisis in terms of personal overdose loss and to assess the policy implications of this loss.” Data was gathered from the COVID-19 and Life Stressors Impact on Mental Health and Well-Being (CLIMB) study, an ongoing longitudinal survey that began in March 2020.
During the fourth wave of the COVID-19 pandemic, 2 new questions were added to the CLIMB survey that dealt with personal overdose loss: “Do you personally know anyone who has died from a drug overdose?” and “Who do you know that has died from a drug overdose?”
